US-based AbbVie’s Allergan Aesthetics announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its CoolAdvantage applicator series, alongside its official market launch in China.
Technology and Features
CoolSculpting utilizes a non-surgical process called cryolipolysis to target and reduce subcutaneous fat by cooling fat cells to a temperature that triggers apoptosis. The vacuum applicator contacts the treatment area, aspirates the tissue into the suction cup, and delivers cooling to the site. The product is approved in 74 markets globally, including the US and Europe, with over 11 million treatment cases.
CoolAdvantage Advancements
The CoolAdvantage series features a vacuum applicator with a three-dimensional (3D) cooling surface, improving upon the first-generation applicator by enhancing treatment temperature and panel shape. The treatment time for the CoolAdvantage series is reduced by 42% compared to the first-generation applicator, with a single site treatment time as short as 35 minutes.
Patient Experience
The 3D cooling surface of the CoolAdvantage applicators effectively reduces skin tension caused by vacuum suction during treatment, improving patient comfort. The applicators are compatible with existing CoolSculpting hosts, allowing doctors to select the appropriate applicator based on patient needs, including body shape, fat volume, and treatment direction.-Fineline Info & Tech
